rs151336937

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001114632.2(JMJD7):​c.779G>A​(p.Arg260His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00587 in 1,613,276 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).

Frequency

Genomes: 𝑓 0.0043 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0060 ( 29 hom. )

Consequence

JMJD7
NM_001114632.2 missense

Scores

18

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: -0.182

Publications

4 publications found
Variant links:
Genes affected
JMJD7 (HGNC:34397): (jumonji domain containing 7) This gene encodes a highly conserved protein with a JmjC domain, which are part of the cupin metalloenzyme superfamily. JmjC proteins may function as 2-oxoglutarate-Fe(II)-dependent dioxygenases. Most tissues also express read-through transcripts from this gene into the downstream phospholipase A2, group IVB (cytosolic) gene, some of which may encode fusion proteins combining the N-terminus of this protein with the phospholipase A2, group IVB protein. [provided by RefSeq, Jul 2008]
JMJD7-PLA2G4B (HGNC:34449): (JMJD7-PLA2G4B readthrough) This locus represents naturally-occurring readthrough transcription between the neighboring jumonji domain containing 7 (JMJD7) and phospholipase A2, group IVB (cytosolic) (PLA2G4B) genes. Readthrough transcripts encode fusion proteins that share amino acid sequence with each individual gene product, including a partial JmjC domain and downstream C2 and phospholipase A2 domains. Alternatively spliced transcript variants have been observed. [provided by RefSeq, Oct 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010764658).
BP6
Variant 15-41836857-G-A is Benign according to our data. Variant chr15-41836857-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 3055559.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JMJD7NM_001114632.2 linkc.779G>A p.Arg260His missense_variant Exon 7 of 8 ENST00000397299.9 NP_001108104.1 P0C870
JMJD7-PLA2G4BNM_005090.4 linkc.702+306G>A intron_variant Intron 6 of 24 NP_005081.1 P0C869-6
JMJD7-PLA2G4BNM_001198588.2 linkc.702+306G>A intron_variant Intron 6 of 23 NP_001185517.1 P0C869-7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JMJD7ENST00000397299.9 linkc.779G>A p.Arg260His missense_variant Exon 7 of 8 1 NM_001114632.2 ENSP00000380467.4 P0C870
JMJD7-PLA2G4BENST00000382448.8 linkc.702+306G>A intron_variant Intron 6 of 24 2 ENSP00000371886.4

Frequencies

GnomAD3 genomes
AF:
0.00434
AC:
660
AN:
152184
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00198
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00406
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00424
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00676
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00407
AC:
1005
AN:
246940
AF XY:
0.00414
show subpopulations
Gnomad AFR exome
AF:
0.00217
Gnomad AMR exome
AF:
0.00247
Gnomad ASJ exome
AF:
0.00161
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00473
Gnomad NFE exome
AF:
0.00653
Gnomad OTH exome
AF:
0.00434
GnomAD4 exome
AF:
0.00604
AC:
8817
AN:
1460974
Hom.:
29
Cov.:
33
AF XY:
0.00596
AC XY:
4333
AN XY:
726780
show subpopulations
African (AFR)
AF:
0.00155
AC:
52
AN:
33476
American (AMR)
AF:
0.00280
AC:
125
AN:
44666
Ashkenazi Jewish (ASJ)
AF:
0.00230
AC:
60
AN:
26112
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000557
AC:
48
AN:
86218
European-Finnish (FIN)
AF:
0.00429
AC:
227
AN:
52916
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5766
European-Non Finnish (NFE)
AF:
0.00724
AC:
8046
AN:
1111762
Other (OTH)
AF:
0.00422
AC:
255
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
534
1069
1603
2138
2672
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
294
588
882
1176
1470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00433
AC:
660
AN:
152302
Hom.:
2
Cov.:
33
AF XY:
0.00414
AC XY:
308
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00197
AC:
82
AN:
41564
American (AMR)
AF:
0.00405
AC:
62
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00424
AC:
45
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00676
AC:
460
AN:
68024
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
35
70
105
140
175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00591
Hom.:
13
Bravo
AF:
0.00460
TwinsUK
AF:
0.00917
AC:
34
ALSPAC
AF:
0.00778
AC:
30
ESP6500AA
AF:
0.00351
AC:
11
ESP6500EA
AF:
0.00726
AC:
52
ExAC
AF:
0.00414
AC:
499
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00567
EpiControl
AF:
0.00599

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

JMJD7-related disorder Benign:1
May 01, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
2.0
DANN
Benign
0.84
DEOGEN2
Benign
0.0024
T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.083
N
LIST_S2
Benign
0.78
T;T
M_CAP
Benign
0.0079
T
MetaRNN
Benign
0.011
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.39
N;.
PhyloP100
-0.18
PROVEAN
Benign
0.46
N;N
REVEL
Benign
0.057
Sift
Benign
0.56
T;T
Sift4G
Benign
0.65
T;T
Polyphen
0.0020
B;.
Vest4
0.18
MVP
0.067
MPC
0.023
ClinPred
0.00049
T
GERP RS
-3.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.077
gMVP
0.39
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151336937; hg19: chr15-42129055; API